Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374197 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Drug-like molecules with activity against Trypanosoma brucei are urgently required as potential therapeutics for the treatment of African sleeping sickness. Starting from known inhibitors of other glycosyltransferases, we have developed the first small molecular inhibitors of dolicholphosphate mannose synthase (DPMS), a mannosyltransferase critically involved in glycoconjugate biosynthesis in T. brucei. We show that these DPMS inhibitors prevent the biosynthesis of glycosylphosphatidylinositol (GPI) anchors, and possess trypanocidal activity against live trypanosomes.
Graphical abstractThe development of thiazolidinones as dolicholphosphate mannose synthase (DPMS) inhibitors and novel trypanocidal agents (ED50 < 100 μM) is reported.Figure optionsDownload full-size imageDownload as PowerPoint slide